Health Benefits of Pulsed Electromagnetic Field Therapy using Bioboosti

Overview

About this study

While the potential clinical uses of pulsed electromagnetic field therapy (PEMF) are extensive, we are focusing on the potential benefits of PEMF on vascular health. We are targeting, the pre diabetic - metabolic syndrome population, a group with high prevalence in the American population. This population tends to be overweight, low fitness, high blood pressure, high triglycerides and borderline high blood glucose.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Individuals diagnosed or with risk factors of metabolic syndrome (i.e., diabetes mellitus, high blood pressure, hypercholesterolemia, hyperglycemia and hyperlipidemia)
  • No history of heart and lung disease

Exclusion Criteria: 

  • Individuals who have participated in a regular exercise program
  • Individuals who do not have any of risk factors 
  • Females who are pregnant, or considering becoming pregnant in the upcoming year

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Bruce Johnson, Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions